These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34452187)

  • 1.
    Liu Q; Gai Y; Chen Y; Lan X; Jiang D
    Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expressing cytotoxic compounds in Escherichia coli Nissle 1917 for tumor-targeting therapy.
    Li R; Helbig L; Fu J; Bian X; Herrmann J; Baumann M; Stewart AF; Müller R; Li A; Zips D; Zhang Y
    Res Microbiol; 2019 Mar; 170(2):74-79. PubMed ID: 30447257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal probiotics
    He L; Yang H; Tang J; Liu Z; Chen Y; Lu B; He H; Tang S; Sun Y; Liu F; Ding X; Zhang Y; Hu S; Xia L
    J Biol Eng; 2019; 13():58. PubMed ID: 31297149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotic Escherichia coli Nissle 1917 propelled micro-robot with pH sensitivity for hypoxia targeted intestinal tumor therapy.
    Wang T; Yin Q; Huang HY; Wang Z; Song H; Luo X
    Colloids Surf B Biointerfaces; 2023 May; 225():113277. PubMed ID: 36996630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor Colonization and Therapy by
    Gentschev I; Petrov I; Ye M; Kafuri Cifuentes L; Toews R; Cecil A; Oelschaeger TA; Szalay AA
    Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High density fermentation of probiotic E. coli Nissle 1917 towards heparosan production, characterization, and modification.
    Datta P; Fu L; Brodfuerer P; Dordick JS; Linhardt RJ
    Appl Microbiol Biotechnol; 2021 Feb; 105(3):1051-1062. PubMed ID: 33481068
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Zhang Y; Ji W; He L; Chen Y; Ding X; Sun Y; Hu S; Yang H; Huang W; Zhang Y; Liu F; Xia L
    Theranostics; 2018; 8(6):1690-1705. PubMed ID: 29556350
    [No Abstract]   [Full Text] [Related]  

  • 8.
    He L; Yang H; Liu F; Chen Y; Tang S; Ji W; Tang J; Liu Z; Sun Y; Hu S; Zhang Y; Liu X; Huang W; Ding X; Xia L
    Oncotarget; 2017 Oct; 8(49):85772-85782. PubMed ID: 29156755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and In Vitro Evaluation of a Tumor Acidic pH-Targeting Drug Delivery System Based on
    Ma Y; Liu Q; Hu A; Jiang S; Wang S; Liu R; Han K; Wang J
    Bioengineering (Basel); 2022 Sep; 9(9):. PubMed ID: 36134979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Engineered Bacteria-Hybrid Microrobot with the Magnetothermal Bioswitch for Remotely Collective Perception and Imaging-Guided Cancer Treatment.
    Chen H; Li Y; Wang Y; Ning P; Shen Y; Wei X; Feng Q; Liu Y; Li Z; Xu C; Huang S; Deng C; Wang P; Cheng Y
    ACS Nano; 2022 Apr; 16(4):6118-6133. PubMed ID: 35343677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxorubicin-conjugated Escherichia coli Nissle 1917 swimmers to achieve tumor targeting and responsive drug release.
    Xie S; Zhao L; Song X; Tang M; Mo C; Li X
    J Control Release; 2017 Dec; 268():390-399. PubMed ID: 29101053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in
    Chen H; Lei P; Ji H; Yang Q; Peng B; Ma J; Fang Y; Qu L; Li H; Wu W; Jin L; Sun D
    Mater Today Bio; 2023 Feb; 18():100543. PubMed ID: 36647536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Escherichia coli Nissle 1917 bacterial ghosts retain crucial surface properties and express chlamydial antigen: an imaging study of a delivery system for the ocular surface.
    Montanaro J; Inic-Kanada A; Ladurner A; Stein E; Belij S; Bintner N; Schlacher S; Schuerer N; Mayr UB; Lubitz W; Leisch N; Barisani-Asenbauer T
    Drug Des Devel Ther; 2015; 9():3741-54. PubMed ID: 26229437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic engineering of probiotic Escherichia coli Nissle 1917 for clinical application.
    Ou B; Yang Y; Tham WL; Chen L; Guo J; Zhu G
    Appl Microbiol Biotechnol; 2016 Oct; 100(20):8693-9. PubMed ID: 27640192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Escherichia coli Nissle 1917 as safe vehicles for intestinal immune targeted therapy--a review].
    Xia P; Zhu J; Zhu G
    Wei Sheng Wu Xue Bao; 2013 Jun; 53(6):538-44. PubMed ID: 24028055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Tumor-selective treatment of metastatic pancreatic cancer with an engineered, probiotic living drug".
    Decker-Farrell AR; Sastra SA; Harimoto T; Hasselluhn MC; Palermo CF; Ballister ER; Badgley MA; Danino T; Olive KP
    bioRxiv; 2024 May; ():. PubMed ID: 38746175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amelioration of cadmium- and mercury-induced liver and kidney damage in rats by genetically engineered probiotic Escherichia coli Nissle 1917 producing pyrroloquinoline quinone with oral supplementation of citric acid.
    Raghuvanshi R; Chaudhari A; Kumar GN
    Nutrition; 2016; 32(11-12):1285-94. PubMed ID: 27209211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-targeted delivery of TAT-Apoptin fusion gene using Escherichia coli Nissle 1917 to colorectal cancer.
    Zhou S; Zhang M; Wang J
    Med Hypotheses; 2011 Apr; 76(4):533-4. PubMed ID: 21256681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial microbots for acid-labile release of hybrid micelles to promote the synergistic antitumor efficacy.
    Xie S; Chen M; Song X; Zhang Z; Zhang Z; Chen Z; Li X
    Acta Biomater; 2018 Sep; 78():198-210. PubMed ID: 30036720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. K5 Capsule and Lipopolysaccharide Are Important in Resistance to T4 Phage Attack in Probiotic
    Soundararajan M; von Bünau R; Oelschlaeger TA
    Front Microbiol; 2019; 10():2783. PubMed ID: 31849915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.